Corporate News

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Haydale (AIM:HAYD), the global nanomaterials group, announces that it has received a further approximate £1.5 million from Everpower, being part of the third tranche of the aggregate £3.26 million strategic investment pursuant to the Subscription Agreement with Everpower announced on 3 February 2017.  Haydale has now received a total of £1.82 million from Everpower pursuant to the Subscription Agreement. Accordingly, application has been made for 878,553 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares") ("Tranche 3 Shares") to be admitted to trading on AIM, with admission expected to occur on or around 3 April 2017 ("Admission").  Following Admission, Everpower's interest in Haydale will be 1,070,281 Ordinary Shares, representing approximately 5.7 per cent. of the Company.

The issue of the balance of the 847,001 Tranche 3 Shares remains subject to the balance of £1.44 million being received by Haydale.  The Board remains confident the outstanding monies will be received, not least because of recent meetings between senior management of both companies, but also pursuant to the terms of the Subscription Agreement, Everpower has requested and Haydale has agreed to extend the Long Stop Date to 30 April 2017.  As a result, Everpower is required to subscribe for a further 191,728 new Ordinary Shares at the Subscription Price ("Extension Shares"). Issue of the Extension Shares remains subject to receipt of approx. £326,000.  Unless otherwise stated, defined terms are set out in the Subscription Agreement announcement issued on 3 February 2017.

The 878,553 new Ordinary Shares will be credited as fully paid and will rank pari passu with the Company's existing Ordinary Shares. Following Admission, the total number of voting rights in the Company will be 18,711,212 Ordinary Shares and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials.  With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness.  Haydale has granted patents for its technologies in Europe, USA and China and operates from four facilities in the UK, USA and the Far East.

For more information, please visit:
www.haydale.com
Twitter: @haydalegraphene

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as "believe", "could", "should" "envisage", "estimate", "intend", "may", "plan", "potentially", "will" or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Haydale (AIM:HAYD), the global nanomaterials group, announces that it has received a further approximate £1.5 million from Everpower, being part of the third tranche of the aggregate £3.26 million strategic investment pursuant to the Subscription Agreement with Everpower announced on 3 February 2017.  Haydale has now received a total of £1.82 million from Everpower pursuant to the Subscription Agreement. Accordingly, application has been made for 878,553 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares") ("Tranche 3 Shares") to be admitted to trading on AIM, with admission expected to occur on or around 3 April 2017 ("Admission").  Following Admission, Everpower's interest in Haydale will be 1,070,281 Ordinary Shares, representing approximately 5.7 per cent. of the Company.

The issue of the balance of the 847,001 Tranche 3 Shares remains subject to the balance of £1.44 million being received by Haydale.  The Board remains confident the outstanding monies will be received, not least because of recent meetings between senior management of both companies, but also pursuant to the terms of the Subscription Agreement, Everpower has requested and Haydale has agreed to extend the Long Stop Date to 30 April 2017.  As a result, Everpower is required to subscribe for a further 191,728 new Ordinary Shares at the Subscription Price ("Extension Shares"). Issue of the Extension Shares remains subject to receipt of approx. £326,000.  Unless otherwise stated, defined terms are set out in the Subscription Agreement announcement issued on 3 February 2017.

The 878,553 new Ordinary Shares will be credited as fully paid and will rank pari passu with the Company's existing Ordinary Shares. Following Admission, the total number of voting rights in the Company will be 18,711,212 Ordinary Shares and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials.  With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness.  Haydale has granted patents for its technologies in Europe, USA and China and operates from four facilities in the UK, USA and the Far East.

For more information, please visit:
www.haydale.com
Twitter: @haydalegraphene

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as "believe", "could", "should" "envisage", "estimate", "intend", "may", "plan", "potentially", "will" or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Haydale (AIM:HAYD), the global nanomaterials group, announces that it has received a further approximate £1.5 million from Everpower, being part of the third tranche of the aggregate £3.26 million strategic investment pursuant to the Subscription Agreement with Everpower announced on 3 February 2017.  Haydale has now received a total of £1.82 million from Everpower pursuant to the Subscription Agreement. Accordingly, application has been made for 878,553 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares") ("Tranche 3 Shares") to be admitted to trading on AIM, with admission expected to occur on or around 3 April 2017 ("Admission").  Following Admission, Everpower's interest in Haydale will be 1,070,281 Ordinary Shares, representing approximately 5.7 per cent. of the Company.

The issue of the balance of the 847,001 Tranche 3 Shares remains subject to the balance of £1.44 million being received by Haydale.  The Board remains confident the outstanding monies will be received, not least because of recent meetings between senior management of both companies, but also pursuant to the terms of the Subscription Agreement, Everpower has requested and Haydale has agreed to extend the Long Stop Date to 30 April 2017.  As a result, Everpower is required to subscribe for a further 191,728 new Ordinary Shares at the Subscription Price ("Extension Shares"). Issue of the Extension Shares remains subject to receipt of approx. £326,000.  Unless otherwise stated, defined terms are set out in the Subscription Agreement announcement issued on 3 February 2017.

The 878,553 new Ordinary Shares will be credited as fully paid and will rank pari passu with the Company's existing Ordinary Shares. Following Admission, the total number of voting rights in the Company will be 18,711,212 Ordinary Shares and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials.  With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness.  Haydale has granted patents for its technologies in Europe, USA and China and operates from four facilities in the UK, USA and the Far East.

For more information, please visit:
www.haydale.com
Twitter: @haydalegraphene

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as "believe", "could", "should" "envisage", "estimate", "intend", "may", "plan", "potentially", "will" or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Haydale (AIM:HAYD), the global nanomaterials group, announces that it has received a further approximate £1.5 million from Everpower, being part of the third tranche of the aggregate £3.26 million strategic investment pursuant to the Subscription Agreement with Everpower announced on 3 February 2017.  Haydale has now received a total of £1.82 million from Everpower pursuant to the Subscription Agreement. Accordingly, application has been made for 878,553 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares") ("Tranche 3 Shares") to be admitted to trading on AIM, with admission expected to occur on or around 3 April 2017 ("Admission").  Following Admission, Everpower's interest in Haydale will be 1,070,281 Ordinary Shares, representing approximately 5.7 per cent. of the Company.

The issue of the balance of the 847,001 Tranche 3 Shares remains subject to the balance of £1.44 million being received by Haydale.  The Board remains confident the outstanding monies will be received, not least because of recent meetings between senior management of both companies, but also pursuant to the terms of the Subscription Agreement, Everpower has requested and Haydale has agreed to extend the Long Stop Date to 30 April 2017.  As a result, Everpower is required to subscribe for a further 191,728 new Ordinary Shares at the Subscription Price ("Extension Shares"). Issue of the Extension Shares remains subject to receipt of approx. £326,000.  Unless otherwise stated, defined terms are set out in the Subscription Agreement announcement issued on 3 February 2017.

The 878,553 new Ordinary Shares will be credited as fully paid and will rank pari passu with the Company's existing Ordinary Shares. Following Admission, the total number of voting rights in the Company will be 18,711,212 Ordinary Shares and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials.  With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness.  Haydale has granted patents for its technologies in Europe, USA and China and operates from four facilities in the UK, USA and the Far East.

For more information, please visit:
www.haydale.com
Twitter: @haydalegraphene

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as "believe", "could", "should" "envisage", "estimate", "intend", "may", "plan", "potentially", "will" or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.